HSBC USA Inc. has announced a new offering of Autocallable Contingent Income Barrier Notes through a recently filed Free Writing Prospectus. This offering is linked to the performance of the Nikkei Stock Average and the iShares MSCI Emerging Markets ETF. The launch of these notes is significant as it showcases HSBC's commitment to diversifying its financial products in the competitive landscape of national commercial banks.

These notes will provide investors with quarterly contingent coupon payments, contingent on the performance of the underlying assets. Specifically, if the official closing value of each underlying is greater than or equal to 60% of its initial value, investors will receive a coupon payment. This structure aims to attract investors looking for potential income while also exposing them to market risks.

HSBC USA Inc., a subsidiary of HSBC Holdings plc, is classified under the SIC code 6021, which denotes National Commercial Banks. The company is incorporated in Maryland and operates from its headquarters in New York City. The recent filing, made on October 30, 2026, is part of a series of filings that include multiple Free Writing Prospectuses and other related documents.

The filing states that the notes will not be listed on any securities exchange, which may limit their liquidity. Additionally, the notes carry certain risks, including the potential loss of principal if the least performing underlying declines significantly. The estimated initial value of the notes is expected to range from $923 to $963 each, which is below the public offering price of $1,000 per note.

HSBC Securities (USA) Inc. has been appointed as the agent for the sale of these notes. This offering is part of HSBC's broader strategy to enhance its product offerings in a competitive market, particularly among other national commercial banks.

Looking ahead, the filing does not specify any immediate next steps following this offering. However, the introduction of these notes may prompt other banks in the sector to consider similar structured products to remain competitive.